Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1

Journal of Experimental Medicine

Volumn 207, Issue 1, 2010, Pages 7-16

  Xi, Hongkang ^a   Katschke Jr , Kenneth J ^a   Helmy, Karim Y ^a   Wark, Paige A ^a,b   Kljavin, Noelyn ^a   Clark, Hilary ^a   Eastham Anderson, Jeffrey ^a   Shek, Theresa ^a   Roose Girma, Merone ^a   Ghilardi, Nico ^a   Van Lookeren Campagne, Menno ^a  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CMRF 35 LIKE MOLECULE 1; CYTOKINE; GLYCOPROTEIN P 15095; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NITRIC OXIDE; PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DEMYELINATION; IMMUNIZATION; INFLAMMATORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SPINAL CORD; T LYMPHOCYTE;

ANIMALS; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCOPROTEINS; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; MYELOID CELLS; NITRIC OXIDE; PEPTIDE FRAGMENTS; RECEPTORS, IMMUNOLOGIC;

EID: 76149141559     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091508     Document Type: Article

References (26)

1. Alvarez-Errico, D., H. Aguilar, F. Kitzig, T. Brckalo, J. Sayós, and M. López-Botet. 2004. IREM-1 is a novel inhibitory receptor expressed by myeloid cells. Eur. J. Immunol. 34:3690-3701. doi:10.1002/eji. 200425433
2. Alvarez-Errico, D., J. Sayós, and M. López-Botet. 2007. The IREM-1 (CD300f) inhibitory receptor associates with the p85alpha subunit of phosphoinositide 3-kinase. J. Immunol. 178:808-816.
3. + common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J. Exp. Med. 206:595-606. doi:10.1084/jem.20081385
4. Auffray, C., M.H. Sieweke, and F. Geissmann. 2009b. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27:669-692. doi:10.1146/annurev.immunol. 021908.132557
5. Bailey, S.L., B. Schreiner, E.J. McMahon, and S.D. Miller. 2007. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 8:172-180. doi:10.1038/ni1430
6. Batten, M., J. Li, S. Yi, N.M. Kljavin, D.M. Danilenko, S. Lucas, J. Lee, F.J. de Sauvage, and N. Ghilardi. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7:929-936. doi:10.1038/ni1375
7. Benveniste, E.N. 1997. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75:165-173. doi:10.1007/s001090050101
8. Can, I., S. Tahara-Hanaoka, K. Hitomi, T. Nakano, C. Nakahashi-Oda, N. Kurita, S. Honda, K. Shibuya, and A. Shibuya. 2008. Caspase-independent cell death by CD300LF (MAIR-V), an inhibitory immunoglobulin-like receptor on myeloid cells. J. Immunol. 180:207-213.
9. Chung, D.H., M.B. Humphrey, M.C. Nakamura, D.G. Ginzinger, W.E. Seaman, and M.R. Daws. 2003. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J. Immunol. 171:6541-6548.
10. Clark, G.J., X. Ju, C. Tate, and D.N. Hart. 2009. The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol. 30:209-217. doi:10.1016/j.it.2009.02.003
11. Deshpande, P., I.L. King, and B.M. Segal. 2007. Cutting edge: CNS CD11c+ cells from mice with encephalomyelitis polarize Th17 cells and support CD25+CD4+ T cell-mediated immunosuppression, suggesting dual roles in the disease process. J. Immunol. 178:6695-6699.
12. Dogan, R.N., A. Elhofy, and W.J. Karpus. 2008. Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF- and iNOS-expressing macrophages and myeloid dendritic cells. J. Immunol. 180:7376-7384.
13. Fischer, H.G., and G. Reichmann. 2001. Brain dendritic cells and macrophages/ microglia in central nervous system inflammation. J. Immunol. 166:2717-2726.
14. Fujimoto, M., H. Takatsu, and H. Ohno. 2006. CMRF-35-like molecule-5 constitutes novel paired receptors, with CMRF-35-like molecule-1, to transduce activation signal upon association with FcRgamma. Int. Immunol. 18:1499-1508. doi:10.1093/intimm/dxl083
15. Geissmann, F., S. Jung, and D.R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 19:71-82. doi:10.1016/S1074-7613(03)00174-2
16. Hooper, D.C., O. Bagasra, J.C. Marini, A. Zborek, S.T. Ohnishi, R. Kean, J.M. Champion, A.B. Sarker, L. Bobroski, J.L. Farber, et al. 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA. 94:2528-2533. doi:10.1073/pnas.94.6.2528
17. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R.M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702. doi:10.1084/jem.176.6.1693
18. Izawa, K., J. Kitaura, Y. Yamanishi, T. Matsuoka, T. Oki, F. Shibata, H. Kumagai, H. Nakajima, M. Maeda-Yamamoto, J.P. Hauchins, et al. 2007. Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3. J. Biol. Chem. 282:17997-18008. doi:10.1074/jbc.M701100200
19. Izawa, K., J. Kitaura, Y. Yamanishi, T. Matsuoka, A. Kaitani, M. Sugiuchi, M. Takahashi, A. Maehara, Y. Enomoto, T. Oki, et al. 2009. An activating and inhibitory signal from an inhibitory receptor LMIR3/ CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells. J. Immunol. 183:925-936. doi:10.4049/jimmunol.0900552
20. King, I.L., T.L. Dickendesher, and B.M. Segal. 2009. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood. 113:3190-3197. doi:10.1182/blood-2008-07-168575
21. Márquez, J.A., E. Galfré, F. Dupeux, D. Flot, O. Moran, and N. Dimasi. 2007. The crystal structure of the extracellular domain of the inhibitor receptor expressed on myeloid cells IREM-1. J. Mol. Biol. 367:310-318. doi:10.1016/j.jmb.2007.01.011
22. Miller, S.D., E.J. McMahon, B. Schreiner, and S.L. Bailey. 2007. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 1103:179-191. doi:10.1196/annals.1394.023
23. Serbina, N.V., T.P. Salazar-Mather, C.A. Biron, W.A. Kuziel, and E.G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 19:59-70. doi:10.1016/S1074- 7613(03)00171-7
24. Shi, L., K. Luo, D. Xia, T. Chen, G. Chen, Y. Jiang, N. Li, and X. Cao. 2006. DIgR2, dendritic cell-derived immunoglobulin receptor 2, is one representative of a family of IgSF inhibitory receptors and mediates negative regulation of dendritic cell-initiated antigen-specific T-cell responses. Blood. 108:2678-2686. doi:10.1182/blood-2006-04-015404
25. Sunnemark, D., S. Eltayeb, M. Nilsson, E. Wallström, H. Lassmann, T. Olsson, A.L. Berg, and A. Ericsson-Dahlstrand. 2005. CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. J. Neuroinflammation. 2:17. doi:10.1186/1742-2094-2-17
26. Yu, X., K. Harden, L.C. Gonzalez, M. Francesco, E. Chiang, B. Irving, I. Tom, S. Ivelja, C.J. Refino, H. Clark, et al. 2009. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 10:48-57. doi:10.1038/ni.1674